Airway microbiome signature accurately discriminates Mycobacterium tuberculosis infection status
Kayongo A, Ntayi M, Olweny G, Kyalo E, Ndawula J, Ssengooba W, Kigozi E, Kalyesubula R, Munana R, Namaganda J, Caroline M, Sekibira R, Bagaya B, Kateete D, Joloba M, Jjingo D, Sande O, Mayanja-Kizza H. Airway microbiome signature accurately discriminates Mycobacterium tuberculosis infection status. IScience 2024, 27: 110142. PMID: 38904070, PMCID: PMC11187240, DOI: 10.1016/j.isci.2024.110142.Peer-Reviewed Original ResearchImmune responseQuantiferon-gold assayMicrobiome signaturesLonger treatment durationTuberculosis infection statusInfection statusDeadly infectious agentsQuantiferon GoldDrug toxicityActive TBLatent TBTreatment durationTherapeutic strategiesPredicting disease susceptibilityFollow-up phaseAirwayMicrobiome diversityInfectious agentsRural UgandaControl TBMycobacterium tuberculosisDisease susceptibilityCohortTuberculosisGeneXpert